Abstract
Background
Ingestion of tea flavonoids found in both green and black tea is linked to cardiovascular health benefits such as lowering serum lipids. Evidence for a cholesterol-lowering benefit of green or black tea consumption from human intervention studies is, however, conflicting and active components responsible for the effect have not yet been clearly identified.
Aim of the study
In a randomized, double-blind, placebo-controlled, parallel design study the effects of ingesting a purified black tea theaflavins (TFs) powder alone or in combination with catechin (TFs/catechins) on lowering serum total (TC) and LDL-cholesterol (LDL-c) were assessed.
Methods
In total, 102 mildly to moderately hypercholesterolemic (TC and LDL-c: 5.70 ± 0.74 and 3.97 ± 0.61 mmol/L, respectively) subjects (67 men and 35 women) were randomly assigned to consume once daily one capsule of one of the 3 treatments: TFs (providing 77.5 mg), TFs/catechins (providing 75.0 mg TFs plus 150.0 mg catechins and 195.0 mg of other polyphenols), or placebo (cellulose).
Results
Serum TC and LDL-c concentrations did not differ significantly among the 3 treatments as assessed at 4, 8, and 11 weeks using analysis of covariance (p = 0.1187 and p = 0.1063, respectively). Although changes over time from baseline to week 11 were significant for TC and LDL-c (p = 0.0311 and p = 0.0269, respectively), this decrease over time was seen in the TFs and placebo groups.
Conclusion
In this human intervention study, no statistically significant LDL-c lowering effect was seen with either TFs alone or the TFs/catechins combination as compared to placebo. Based on these findings it cannot be concluded that tea flavonoids such as theaflavins and catechins are responsible for a putative cholesterol-lowering effect of black tea, at least not with the daily dose applied in the present study.
Similar content being viewed by others
References
Bingham SA, Vorster H, Jerling JC, Magee E, Mulligan A, Runswick SA, Cummings JH (1997) Effect of black tea drinking on blood lipids, blood pressure and aspects of bowel habit. Br J Nutr 78:41–55
Davies MJ, Judd JT, Baer DJ, Clevidence BA, Paul DR, Edwards AJ, Wiseman SA, Muesing RA, Chen SC (2003) Black tea consumption reduces total and LDL cholesterol in mildly hypercholesterolemic adults. J Nutr 133:3298S–3302S
Doornbos AM, Meynen EM, Duchateau GS, van der Knaap HC, Trautwein EA (2006) Intake occasion affects the serum cholesterol lowering of a plant sterol-enriched single-dose yoghurt drink in mildly hypercholesterolaemic subjects. Eur J Clin Nutr 60:325–333
Du S, Lu B, Zhai F, Popkin BM (2002) A new stage of the nutrition transition in China. Public Health Nutr 5:169–174
Erba D, Riso P, Bordoni A, Foti P, Biagi PL, Testolin G (2005) Effectiveness of moderate green tea consumption on antioxidative status and plasma lipid profile in humans. J Nutr Biochem 16:144–149
Fujita H, Yamagami T (2008) Antihypercholesterolemic effect of Chinese black tea extract in human subjects with borderline hypercholesterolemia. Nutr Res 28:450–456
Fukino Y, Ikeda A, Maruyama K, Aoki N, Okubo T, Iso H (2008) Randomised controlled trial for an effect of green tea-extract power supplementation on glucose abnormalities. Eur J Clin Nutr 62:953–960. doi:10.1038/sj.ejcn.1602806 published online 6 June 2007
Guo X, Popkin BM, Zhai F (1999) Patterns of change in food consumption and dietary fat intake in Chinese adults, 1989–1993. Food Nutr Bull 20:344–353
Hodgson JM (2008) Tea flavonoids and cardiovascular disease. Asia Pac J Clin Nutr 17:288–290
Hsu TF, Kusumoto A, Abe K, Hosoda K, Kiso Y, Wang MF, Yamamoto S (2006) Polyphenol-enriched oolong tea increases fecal lipid excretion. Eur J Clin Nutr 60:1330–1336
Huxley JM, Neil HA (2003) The relation between dietary flavonol intake and coronary heart disease mortality: a meta-analysis of prospective cohort studies. Eur J Clin Nutr 57:904–908
Ikeda I, Imasato Y, Sasaki E, Nakayama M, Nagao H, Takeo T, Yayabe F, Sugano M (1992) Tea catechins decrease micellar solubility and intestinal absorption of cholesterol in rats. Biochim Biophys Acta 1127:141–146
Ikeda I, Kobayashi M, Hamada T, Tsuda K, Goto H, Imaizumi K, Nozawa A, Sugimoto A, Kakuda T (2003) Heat-epimerized tea catechins rich in gallocatechin gallate and catechin gallate are more effective to inhibit cholesterol absorption than tea catechins rich in epigallocatechin gallate and epicatechin gallate. J Agric Food Chem 51:7303–7307
Ishikawa T, Suzukawa M, Ito T, Yoshida H, Ayaori M, Nishiwaki M, Yonemura A, Hara Y, Nakamura H (1997) Effect of tea flavonoid supplementation on the susceptibility of low-density lipoprotein to oxidative modification. Am J Clin Nutr 66:261–266
Koo SI, Noh SK (2007) Green tea as inhibitor of the intestinal absorption of lipids: Potential mechanism for its lipid-lowering effect. J Nutr Biochem 18:179–183
Kris-Etherton PM, Dietschy J (1997) Design criteria for studies examining individual fatty acid effects on cardiovascular disease risk factors: human and animal studies. Am J Clin Nutr 65(Suppl):1590S–1596S
Maron DJ, Lu GP, Cai NS, Wu ZG, Li YH, Chen H, Zhu JQ, Jin XJ, Wouters BC, Zhao J (2003) Cholesterol-lowering effect of a theaflavin-enriched green tea extract: a randomized controlled trial. Arch Intern Med 163:1448–1453
McAnlis GT, McEnery J, Pearce J, Young IS (1998) Black tea consumption does not protect low density lipoprotein from oxidative modification. Eur J Clin Nutr 52:202–206
Mulder TPJ, van Platerink CJ, Schuyl PJW, van Amelsvoort JMM (2001) Analysis of theaflavins in biological fluids using liquid chromatography-electrospray mass spectrometry. J Chromatogr 760:271–279
Peters U, Poole C, Arab L (2001) Does tea affect cardiovascular disease? A meta-analysis. Am J Epidemiol 154:495–503
Princen HM, van Duyvenvoorde W, Buytenhek R, Blonk C, Tijburg LB, Langius JA, Meinders AE, Pijl H (1998) No effect of consumption of green and black tea on plasma lipid and antioxidant levels and on LDL oxidation in smokers. Atheroscler Thromb Vasc Biol 18:833–841
Raederstorff DG, Schlachter MF, Elste V, Weber P (2003) Effect of EGCG on lipid absorption and plasma lipid levels in rats. J Nutr Biochem 14:326–332
Stangl V, Lorenz M, Stangl K (2006) The role of tea and tea flavonoids in cardiovascular health. Mol Nutr Food Res 50:218–228
van het Hof K, de Boer HSM, Wiseman SA, Lien N, Weststrate JA, Tijburg LBM (1997) Consumption of green or black tea does not increase resistance of low-density-lipoprotein to oxidation in humans. Am J Clin Nutr 66:1123–1132
Vermeer M, Mulder T, Molhuizen H (2008) Theaflavins from black tea, especially theaflavin-3-gallate, reduce the incorporation of cholesterol into mixed micelles. J Agric Food Chem 56:12031–12036
Balentine DA, Wiseman SA, Bouwens LC (1997) The chemistry of tea flavonoids. Crit Rev Food Sci Nutr 37:693–704
Warden BA, Smith LS, Beecher GR, Balentine DA, Clevidence BA (2001) Catechins are bioavailable in men and women drinking black tea throughout the day. J Nutr 131:1731–1737
Trautwein EA, Duchateau GS, Lin YG, Mel’nikov SM, Molhuizen HOF, Ntanios FY (2003) Proposed mechanisms of cholesterol-lowering action of plant sterols. Eur J Lipid Sci Technol 105:171–185
Acknowledgments
The authors like to thank Dr. Yi-Cai Fu for his help in the identification of the clinical study site, Dr. Wei-Li Li for his role as company physician, Yong-Shi Bu for helping with capsule preparation, and Mario Vermeer for critical comments on the manuscript.
Conflict of interest statement
All authors are employed by Unilever Foods, The Netherlands or China.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Trautwein, E.A., Du, Y., Meynen, E. et al. Purified black tea theaflavins and theaflavins/catechin supplements did not affect serum lipids in healthy individuals with mildly to moderately elevated cholesterol concentrations. Eur J Nutr 49, 27–35 (2010). https://doi.org/10.1007/s00394-009-0045-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00394-009-0045-7